fda ruling semaglutide 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these FDA free to pursue semaglutide

A., Sakatani, T., Sugamura, K., Makino, M., Ito, H., Savaraj, N., Kaibara, N., and Kuo, M

Elevated risks of coronary artery disease and heart failure persisted in those who discontinued early, while risks of acute coronary syndromes, stroke, and mortality were similar between groups

No potential mutagenicity of tesamorelin acetate was revealed in a battery of tests including induction of gene mutations in bacteria (the Ames test), gene mutations in mammalian cells grown in vitro (hamster CHOK1 cells), and chromosomal damage in intact animals (bone marrow cells in mice)

This GSH down modulation was followed by change in cytokine profile

For shoulder tendons with poor vascular supply, this is potentially transformative

Resume your schedule per the label and call our office if youre unsure